Product
DREP-HIV-PT1
1 clinical trial
1 indication
Indication
Healthy AdultsClinical trial
EHVA P01/ANRS VRI08: A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected AdultsStatus: Active (not recruiting), Estimated PCD: 2024-09-30